Marzetti is trading 4.1% lower at $105.37 after fiscal first-quarter results missed expectations. - Results reported November 3 showed sales down 2.4% to $481.5 million and adjusted diluted EPS of $1.14 versus $1.37 analyst consensus. - Management cited the Cyclospora outbreak and higher freight costs, maintaining its mid-single-digit full-year sales growth outlook but lowering its gross-margin expansion forecast to 25–75 basis points. - Previous close was $109.88; the broader pre-market consumer-staples trend was positive.